INHIBITION OF CHOLESTEROL AND SPHINGOLIPID SYNTHESIS CAUSES PARADOXICAL EFFECTS ON PERMEABILITY BARRIER HOMEOSTASIS

被引:30
|
作者
MAN, MQ
FEINGOLD, KR
ELIAS, PM
机构
[1] VET ADM MED CTR,DERMATOL SERV 190,4150 CLEMENT ST,SAN FRANCISCO,CA 94121
[2] VET ADM MED CTR,METAB SECT,SAN FRANCISCO,CA 94121
[3] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT DERMATOL,SAN FRANCISCO,CA 94143
[4] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT CHEM,SAN FRANCISCO,CA 94143
关键词
D O I
10.1111/1523-1747.ep12363729
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cholesterol, fatty acid, and sphingolipid synthesis are required for barrier homeostasis, as demonstrated by studies where synthesis of these species is stimulated in parallel with barrier repair. Moreover, blockade of synthesis of these lipids with inhibitors of two of the rate-limiting enzymes, HMGCoA reductase (lovastatin, fluvastatin) and serine palmitoyl transferase (beta-chloroalanine), alters the kinetics of barrier repair. Whereas these studies demonstrated a requirement for these lipids individually, we asked here whether these lipids are required in either an additive or cooperative fashion. We applied each class of inhibitor alone or the two classes of inhibitors together to acetone-treated skin, or each class separately to essential fatty acid deficient murine skin. When fluvastatin or beta-chloroalanine was applied individually to acetone-treated skin, each caused a delay in the early or late stages of barrier recovery, respectively (assessed as transepidermal water loss). However, when applied together they caused no further worsening at the early time point and a paradoxical improvement at the later time points. This improvement correlated with an accelerated return of sphingolipids, which was perhaps due to a global stimulation of lipid synthesis induced by HMGCoA reductase inhibitors. In essential fatty acid deficient animals, inhibition of HMGCoA reductase caused drastic worsening of both clinical appearance and barrier function, but beta-chloroalanine caused a paradoxical improvement, which correlated with a significant reduction in epidermal sphingolipids. These results are consistent with a requirement for both cholesterol and sphingolipids for barrier homeostasis, and also with the suggestion that both of these lipids must be present (with free fatty acids) for optimal barrier function.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 45 条
  • [31] Epidermal permeability barrier function regulates mRNA levels for the key enzymes of cholesterol, fatty acid and ceramide synthesis.
    Harris, IR
    Farrell, AM
    Dickson, RC
    Holleran, W
    Grunfeld, C
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 100 - 100
  • [32] Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis
    Harris, IR
    Farrell, AM
    Grunfeld, C
    Holleran, WM
    Elias, PM
    Feingold, KR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (06) : 783 - 787
  • [33] A REGULATORY ROLE FOR SPHINGOLIPIDS IN NEURONAL GROWTH - INHIBITION OF SPHINGOLIPID SYNTHESIS AND DEGRADATION HAVE OPPOSITE EFFECTS ON AXONAL BRANCHING
    SCHWARZ, A
    RAPAPORT, E
    HIRSCHBERG, K
    FUTERMAN, AH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 10990 - 10998
  • [34] Adrenomedullin causes coronary vasodilation in humans - Effects of inhibition of nitric oxide synthesis
    Ueda, K
    Teragawa, H
    Kimura, M
    Matsuda, K
    Higashi, Y
    Yamagata, T
    Oshima, T
    Yoshizumi, M
    Chayama, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 534 - 539
  • [35] PREDNISONE EFFECTS ON BLOOD-BRAIN-BARRIER PERMEABILITY AND CNS IGG SYNTHESIS IN HEALTHY HUMANS
    WOLKOWITZ, OM
    PAPADOPOULOS, NM
    COSTELLO, R
    BREIER, A
    DORAN, AR
    PICKAR, D
    RUBINOW, D
    PSYCHONEUROENDOCRINOLOGY, 1990, 15 (02) : 155 - 158
  • [36] Immune activation by Yersinia pseudotuberculosis mitogen (YPM) causes increased epithelial permeability that is prevented by inhibition of prostaglandin synthesis.
    McKay, DM
    Donnelly, G
    Takeda, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S192 - S192
  • [37] EFFECTS OF INHIBITION OF CHOLESTEROL-SYNTHESIS BY SIMVASTATIN ON THE PRODUCTION OF ADRENOCORTICAL STEROID-HORMONES AND ACTH
    MOL, MJTM
    STALENHOEF, AFH
    STUYT, PMJ
    HERMUS, ARMM
    DEMACKER, PNM
    VANTLAAR, A
    CLINICAL ENDOCRINOLOGY, 1989, 31 (06) : 679 - 689
  • [38] EFFECTS OF CHOLESTEROL-SYNTHESIS INHIBITION ON LIPID-METABOLISM IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS
    MOL, MJ
    STALENHOEF, AF
    DEMACKER, PN
    ARTERIOSCLEROSIS, 1987, 7 (05): : A501 - A501
  • [39] GLUCOCORTICOID EFFECTS ON LIPID-METABOLISM IN HELA-CELLS - INHIBITION OF CHOLESTEROL-SYNTHESIS AND INCREASED SPHINGOMYELIN SYNTHESIS
    JOHNSTON, D
    MATTHEWS, ER
    MELNYKOVYCH, G
    ENDOCRINOLOGY, 1980, 107 (05) : 1482 - 1488
  • [40] IMMATURE CHICKENS TREATED WITH ETHAMOXYTRIPHETOL (MER25) - EXTRANEURAL EFFECTS AND INHIBITION OF CHOLESTEROL SYNTHESIS IN BRAIN
    GRANICH, M
    TIMIRAS, PS
    FEDERATION PROCEEDINGS, 1970, 29 (02) : A347 - +